Dysfunctional HDL and atherosclerotic cardiovascular disease

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Atherosclerosis Research

Background:

• High-density lipoproteins (HDL) are crucial in preventing atherosclerosis via reverse cholesterol transport.
• HDL possesses anti-inflammatory, antioxidative, and endothelial function-restoring properties that inhibit disease progression.
• Systemic and vascular inflammation are implicated in converting HDL into a dysfunctional state.

Purpose of the Study:

• To elucidate the mechanisms by which HDL becomes dysfunctional.
• To understand the role of inflammation and specific enzymes in HDL dysfunction.
• To explore the clinical implications of dysfunctional HDL in atherosclerosis.

Main Methods:

• Investigated the role of ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1) in HDL function.
• Examined the impact of inflammation on HDL's antiatherogenic properties.
• Studied the effects of myeloperoxidase on apolipoprotein A-I and HDL functionality.

Main Results:

• Dysfunctional HDL exhibits impaired cholesterol transport via ABCA1 and ABCG1 pathways.
• Inflammation leads to a loss of protective proteins and gain of pro-inflammatory proteins in HDL.
• Myeloperoxidase-induced modifications of apolipoprotein A-I render HDL dysfunctional, increasing coronary artery disease risk.

Conclusions:

• Inflammation-induced HDL dysfunction significantly contributes to atherogenesis.
• Understanding HDL and apolipoprotein A-I dysfunction offers potential for new diagnostic and therapeutic strategies.
• Targeting HDL dysfunction may provide novel approaches to managing atherosclerosis and coronary artery disease.